15 November 2024 in Science Advances
Developing instant detection systems with disease diagnostic capabilities holds immense importance for remote or resource-limited areas. However, the task of creating these systems—which are simultaneously easy to operate, rapid in detection, and cost-effective—remains a challenge. In this study, we present a compact highly sensitive photothermal reverse transcriptase–loop-mediated isothermal amplification (RT-LAMP) chip (SPRC) designed for the detection of multiple diseases. The nucleic acid (NA) amplification on the chip is achieved through LAMP driven by either LED illumination or simple sunlight focusing. SPRC performs sample addition and amplification within a limited volume and autonomous enrichment of NA during the sample addition process, achieving a limit of detection (LOD) as low as 0.2 copies per microliter. Through 120 clinical samples, we achieved an accuracy of 95%, with a specificity exceeding 97.5%. Overall, SPRC has achieved promising progress in the application of point-of-care testing (POCT) by using light energy to simultaneously detect multiple diseases.
8 August 2025 in Science Advances
Rapid and accurate disease diagnosis in resource-limited settings is critical for optimizing medical resources and controlling epidemic outbreaks. However, developing a point-of-care detection system that is user-friendly, cost-effective, highly accurate, and exhibits strong specificity remains a formidable challenge. Here, we report an integrated horizontal convection PCR system (IHCS) for clinical point-of-care testing, capable of real-time fluorescence detection. IHCS leverages horizontal thermal convection within a capillary to drive sample flow and temperature cycling for nucleic acid amplification, making it suitable for both home use and on-site rapid detection. Capillary action enables swift sample loading, thereby simplifying the overall procedure, and the horizontal thermal convection overcomes the volume limitations inherent in vertical systems. Validation with 130 clinical samples demonstrated that the system successfully detected HBV, SARS-CoV-2, and influenza A virus within 40 min, achieving excellent sensitivity (>96%) and specificity (100%). Overall, the IHCS integrates microfluidics, thermal engineering, and optical sensing and offers a paradigm-shifting solution for point-of-care diagnostics.
31 December 2024 in Sensors and Actuators B: Chemical